Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Thompson Michelle

20 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 7 Safety 6 Receptor Pharmacology 6 Clinical Trial 5 Observational Study 5 Mechanism of Action 4 Adverse Events 3 Addiction 3 Anxiety 3 Emotional Processing 3 Cancer Patients 2 Microdosing 2

Journals

Drug and Alcohol Dependence 2 Frontiers in psychiatry 2 Journal of pain and symptom management 1 Rand health quarterly 1 SLEEPJ 1 Addiction 1 Neuro-Oncology 1 EClinicalMedicine 1

Publication history

Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis.Journal of pain and symptom management · 2026-08-03 U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.Rand health quarterly · 2026-06-01 0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart StudySLEEPJ · 2026-05-08 Psilocybin microdosing in the United States: Insights from a nationally representative surveyAddiction · 2026-03-08 CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-11-01 Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.EClinicalMedicine · 2024-10-01 Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology · 2024-08-01 Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01 High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08 Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2024-01-01 Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.Psychological medicine · 2024-01-01 Extended difficulties following the use of psychedelic drugs: A mixed methods studyPLoS ONE · 2023-10-23 Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial.Frontiers in psychiatry · 2023-01-01 Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.Cureus · 2022-05-01 Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.Frontiers in psychiatry · 2022-01-01 Trial of Psilocybin versus Escitalopram for Depression.The New England journal of medicine · 2021-04-15 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-01 Psychedelic use and intimate partner violence: The role of emotion regulation.Journal of psychopharmacology (Oxford, England) · 2018-07-01 Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.Journal of analytical toxicology · 2007-10-01

Author directory